PM

Philip Morris Intl

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Consumer Defensive

industry

Tobacco

Exchange

NYSE

County of HQ

United States

Next Earnings Date

04/22/26

Business Summary

Philip Morris Intl monetizes addictive, brand-driven tobacco products with global pricing power and entrenched distribution networks. The business converts recurring consumer demand into predictable cash flows, which supports dividends and reinvestment at high returns on capital. Its moat rests on brand equity, regulatory barriers to entry, and scale efficiencies across manufacturing and distribution. The result is a capital-light, high-ROIC model that turns steady demand into durable shareholder returns.

VALUATION

P/E

22.1

Market Cap ($M USD)

$250,066

Forward P/E

17.4

PEG

-

PRICE TO SALES

6.2

PRICE TO BOOK

-

EV / EBITDA

16.8

5-Year Average P/E

DIVIDEND

Yield

3.60%

Annual Payout

$5.88

Payout Ratio

77.60%

Consecutive Years of Dividend Growth

10+

5-Year Dividend Growth Rate

4.10%

Financial Health & Profitability

Earnings Per Share

$7.27

Next Year EPS Growth Estimate

$9.20

Next Year Revenue Growth Estimate

6.90%

Return on Equity (ROE)

-113.20%

Operating Margin

36.70%

Debt-to-Equity

-

Piotroski F-Score

6

Altman Z-Score

3.9

Return on Invested Capital (ROIC)

33.20%%

Current Ratio

1

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At 22.1x earnings and 17.4x forward earnings, the market is pricing Philip Morris Intl as a stable compounder rather than a distressed defensive name. The forward multiple implies earnings acceleration relative to the current P/E, yet the Altman Z-Score of 3.9 signals solid balance sheet stability and low bankruptcy risk, which underpins valuation support. With a Market Cap of $250,066M and ROIC at 33.20%, this is not a melting-ice-cube valuation — it’s a high-return enterprise priced at a reasonable GARP multiple, suggesting the market is not dramatically mispricing it but may be underappreciating the durability of its capital efficiency.

AI Exposure / Tech Reliance

As a Consumer Defensive Tobacco company, AI disruption risk is minimal; demand patterns are habit-driven, not tech-driven. Operationally, AI can enhance supply chain efficiency and pricing analytics, but it won’t redefine the core product economics. This is a resilience story, not an AI growth story.

The Bull Case

A GARP or quality-value investor buys this because 33.20% ROIC is elite — that level of capital efficiency justifies a premium multiple and signals strong pricing power. The Piotroski F-Score of 6 reflects decent fundamental health, and despite headline noise in Operating Margin at -113.20%, the company still generates enough profitability to sustain a 3.60% dividend with a payout ratio of $5.88 and a 5-year average dividend growth above 10+. Institutional Ownership at $197.50 and a Consensus Rating of 1.10% indicate strong professional sponsorship, while a Short % of Float at 4.10% shows limited bearish conviction. Add in a Current Ratio of 1 and Altman Z-Score of 3.9, and you have a financially stable cash engine trading at a forward multiple that leaves room for upside if execution remains intact.

The Bear Case

There are real structural concerns. Operating Margin at -113.20% is a glaring anomaly that demands scrutiny, and Debt/Equity at 36.70% introduces leverage sensitivity in a rising-rate or regulatory tightening environment. The absence of a PEG Forward figure removes visibility into growth-adjusted valuation, EPS of 16.8 versus EPS Next Year (Est.) of $7.27 raises earnings consistency questions, and Sales Growth Next Year listed at $9.20 provides limited clarity. With a Price/Sales of 6.2 in a slow-growth defensive sector, any regulatory shock or volume contraction could compress multiples quickly.

Market Sentiment & Smart Money

Short Interest %

1.10%

Analyst Consensus

1.68

Average Analyst Price Target

$197.50

Institutional Ownership %

83.10%

1-Year Beta

0

Insider Buying % (6 Mo)

0.20%%

Distance to 52-Week High

83.90%%

Distance to 52-Week Low

112.90%%